 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||||| WIBP Inactivated COVID-19 vaccine (Omicron) / Sinopharm
Enrollment closed, Trial completion date, Trial primary completion date: Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and Above (clinicaltrials.gov) - Jun 18, 2023
P3, N=1804, Active, not recruiting, Sponsor: China National Biotec Group Company Limited
Recruiting --> Active, not recruiting | Trial completion date: Nov 2023 --> Mar 2024 | Trial primary completion date: Nov 2022 --> Jul 2023
- |||||| WIBP Inactivated COVID-19 vaccine (Omicron) / Sinopharm
Enrollment open: Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and Above (clinicaltrials.gov) - Jun 2, 2022
P3, N=1800, Recruiting, Sponsor: China National Biotec Group Company Limited
Recruiting --> Active, not recruiting | Trial completion date: Nov 2023 --> Mar 2024 | Trial primary completion date: Nov 2022 --> Jul 2023 Not yet recruiting --> Recruiting
- |||||||||| WIBP Inactivated COVID-19 vaccine (Omicron) / Sinopharm
New P3 trial: Sequential Immunization of Two Doses of Inactivated COVID-19 Vaccine (Omicron) in Vaccinated Population Aged 18 Years and Above (clinicaltrials.gov) - May 18, 2022
P3, N=1800, Not yet recruiting, Sponsor: China National Biotec Group Company Limited